The SRDX chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the SRDX chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.
The SRDX stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.
|View SRDX Detailed Price Forecast - CNN Money||View SRDX Detailed Summary - Google Finance|
|View SRDX Detailed Summary - Yahoo! Finance||View SRDX Stock Research & Analysis - Zacks.com|
|View SRDX Trends & Analysis - Trade-Ideas||View SRDX Major Holders - Barrons|
|View SRDX Call Transcripts - NASDAQ||View SRDX Breaking News & Analysis - Seeking Alpha|
|View SRDX Annual Report - CompanySpotlight.com||View SRDX OTC Short Report - OTCShortReport.com|
|View SRDX Fundamentals - TradeKing||View SRDX SEC Filings - Bar Chart|
|View Historical Prices for SRDX - The WSJ||View Performance/Total Return for SRDX - Morningstar|
|View the Analyst Estimates for SRDX - MarketWatch||View the Earnings History for SRDX - CNBC|
|View the SRDX Earnings - StockMarketWatch||View SRDX Buy or Sell Recommendations - MacroAxis|
|View the SRDX Bullish Patterns - American Bulls||View SRDX Short Pain Metrics - ShortPainBot.com|
|View SRDX Stock Mentions - StockTwits||View SRDX Stock Mentions - PennyStockTweets|
|View SRDX Stock Mentions - Twitter||View SRDX Investment Forum News - Investor Hub|
|View SRDX Stock Mentions - Yahoo! Message Board||View SRDX Stock Mentions - Seeking Alpha|
|View Insider Transactions for SRDX - SECform4.com||View Insider Transactions for SRDX - Insider Cow|
|View SRDX Major Holdings Summary - CNBC||View Insider Disclosure for SRDX - OTC Markets|
|View Insider Transactions for SRDX - Yahoo! Finance||View Institutional Holdings for SRDX - NASDAQ|
|View SRDX Stock Insight & Charts - FinViz.com||View SRDX Investment Charts - StockCharts.com|
|View SRDX Stock Overview & Charts - BarChart||View SRDX User Generated Charts - Trading View|
Biothera Pharmaceuticals Appoints Andrew D.C. LaFrence Chief Financial Officer
Posted on Wednesday May 16, 2018
EAGAN, Minn., May 16, 2018-- Biothera Pharmaceuticals, Inc., announced the appointment of Andrew D.C. LaFrence, CPA as Senior Vice President and Chief Financial Officer, effective May 29. Biothera Pharmaceuticals ...
Surmodics Announces Leadership Change and Appointment of Interim CFO
Posted on Wednesday May 16, 2018
Surmodics, Inc. (SRDX), a leading provider of medical device and in vitro diagnostic technologies to the healthcare industry, announced today Andrew LaFrence will resign as Chief Financial Officer (CFO) effective May 25, 2018. Following LaFrence’s departure, Timothy J. Arens, Vice President of Corporate Development and Strategy, will serve as interim CFO. “We greatly appreciate the contributions Andy has made during his tenure at Surmodics and wish him the best in his future endeavors,” said Gary Maharaj, President and Chief Executive Officer of Surmodics.
Surmodics (SRDX) Hits a 52-Week High, Can the Run Continue?
Posted on Tuesday May 15, 2018
Surmodics, Inc. is at a 52-week high, but can investors hope for more gains in the future? We take a look at the fundamentals for SRDX for clues.
Surmodics, Inc. (SRDX), a leading provider of medical device and in vitro diagnostic technologies to the healthcare industry, announced today it has reached an agreement with Embolitech to acquire an innovative thrombectomy platform technology and related intellectual property with broad potential peripheral vascular applications. Under the agreement, Surmodics will pay $5 million up front, and additional amounts related to various regulatory milestones. The addition of this technology to the Surmodics peripheral vascular pipeline strengthens the company’s focus on developing highly differentiated whole-product solutions for its medical device customers.